Shows biased agonism of PAR2 in oral cancers, suggesting improved pain management methods.
activation in oral N+ cancers from patients with pain is driven by high levels of MMP1 and PRSS23. Our study informs design of signaling and location-specific antagonists to provide more efficacious analgesia.
No takes yet. Share an insight, caveat, or question.
Ramírez-García et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: